These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7629504)

  • 1. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness.
    Abastado JP; Lone YC; Casrouge A; Boulot G; Kourilsky P
    J Exp Med; 1995 Aug; 182(2):439-47. PubMed ID: 7629504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC.
    Schneck J; Maloy WL; Coligan JE; Margulies DH
    Cell; 1989 Jan; 56(1):47-55. PubMed ID: 2783386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cytotoxic T lymphocyte induction using peptide-stripped autologous cells.
    Langlade-Demoyen P; Levraud JP; Kourilsky P; Abastado JP
    Int Immunol; 1994 Nov; 6(11):1759-66. PubMed ID: 7865468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of phosphorylation and internalization of the antigen receptor/CD3 complex, CD8, and class I MHC-encoded proteins on T cells. Role of intracytoplasmic domains analyzed with hybrid CD8/class I molecules.
    Boyer C; Auphan N; Gabert J; Blanc D; Malissen B; Schmitt-Verhulst AM
    J Immunol; 1989 Sep; 143(6):1905-14. PubMed ID: 2506271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
    Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
    J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex.
    Grégoire C; Lin SY; Mazza G; Rebai N; Luescher IF; Malissen B
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7184-9. PubMed ID: 8692966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses.
    Kageyama S; Tsomides TJ; Sykulev Y; Eisen HN
    J Immunol; 1995 Jan; 154(2):567-76. PubMed ID: 7814868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.
    Brock R; Wiesmüller KH; Jung G; Walden P
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13108-13. PubMed ID: 8917552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
    Belyakov IM; Kozlowski S; Mage M; Ahlers JD; Boyd LF; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Dec; 19(12):1413-20. PubMed ID: 17981793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
    Casares S; Zong CS; Radu DL; Miller A; Bona CA; Brumeanu TD
    J Exp Med; 1999 Aug; 190(4):543-53. PubMed ID: 10449525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density.
    Motta I; Lone YC; Kourilsky P
    Eur J Immunol; 1998 Nov; 28(11):3685-95. PubMed ID: 9842911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.